Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Authors
Keywords
Prolactinoma, Dopamine agonist, Resistance, Aggressive prolactinoma
Journal
Pituitary
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-14
DOI
10.1007/s11102-019-00987-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas
- (2019) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aggressive and malignant prolactinomas
- (2019) Nicoleta Olarescu et al. NEUROENDOCRINOLOGY
- THE EFFECT OF RALOXIFENE ON SERUM PROLACTIN LEVEL IN PATIENTS WITH PROLACTINOMA
- (2019) Chitra Choudhary et al. Endocrine Practice
- Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor
- (2019) Filippo Ceccato et al. ANTI-CANCER DRUGS
- Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
- (2019) G Giuffrida et al. Endocrine Connections
- miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma
- (2019) Bin Hu et al. BRAIN RESEARCH BULLETIN
- Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma
- (2019) Eva C Coopmans et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study
- (2018) Xiaohai Liu et al. World Neurosurgery
- Early recognition and initiation of temozolomide chemotherapy for refractory, invasive pituitary macroprolactinoma with long-term sustained remission: a case report
- (2018) Garni Barkhoudarian et al. World Neurosurgery
- Pasireotide: A potential therapeutic alternative for resistant prolactinoma
- (2018) Hélène Lasolle et al. ANNALES D ENDOCRINOLOGIE
- Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway
- (2018) Chao Wang et al. Molecular Medicine Reports
- Association of prolactin receptor (PRLR) variants with prolactinomas
- (2018) Caroline M Gorvin et al. HUMAN MOLECULAR GENETICS
- Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts
- (2018) Jun Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Management of dopamine agonist-resistant prolactinoma
- (2018) Dominique Maiter NEUROENDOCRINOLOGY
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas
- (2017) María García-Barrado et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine
- (2017) Shao Jian Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection
- (2017) Waseem Touma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Treatment of aggressive prolactinoma with temozolomide
- (2017) Cheng Chen et al. MEDICINE
- ESR1 and its antagonist fulvestrant in pituitary adenomas
- (2017) Hua Gao et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide
- (2016) James Felker et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup
- (2016) Ze Rui Wu et al. International Journal of Endocrinology
- Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth
- (2015) E. Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Macroprolactinomas in Children and Adolescents: Factors Associated With the Response to Treatment in 77 Patients
- (2015) Sylvie Salenave et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
- (2015) M Victoria Recouvreux et al. JOURNAL OF ENDOCRINOLOGY
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas
- (2015) Zhenye Li et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
- (2014) Eric Monsalves et al. ENDOCRINE-RELATED CANCER
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Resistant prolactinomas
- (2014) V. Vasilev et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models
- (2014) Lei Cao et al. JOURNAL OF NEURO-ONCOLOGY
- Local Transformations of Androgens into Estradiol by Aromatase P450 Is Involved in the Regulation of Prolactin and the Proliferation of Pituitary Prolactin-Positive Cells
- (2014) María José García Barrado et al. PLoS One
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
- (2012) Niki Karavitaki et al. CLINICAL ENDOCRINOLOGY
- Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
- (2012) Laurent Vroonen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients
- (2012) V. Primeau et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior
- (2012) Hakan Akinci et al. Pituitary
- First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
- (2012) S. Baldari et al. Pituitary
- Expression and function of ErbB receptors and ligands in the pituitary
- (2011) Odelia Cooper et al. ENDOCRINE-RELATED CANCER
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Radiation Therapy in the Management of Pituitary Adenomas
- (2011) Jay S. Loeffler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- New targeted therapies in pituitary carcinoma resistant to temozolomide
- (2011) Emmanuel Jouanneau et al. Pituitary
- Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis
- (2011) Vania dos Santos Nunes et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Achievement of Fertility in an Infertile Man with Resistant Macroprolactinoma Using High-Dose Bromocriptine and a Combination of Human Chorionic Gonadotropin and an Aromatase Inhibitor
- (2010) Zahra Heidari et al. Endocrine Practice
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy
- (2010) Hidenori Fukuoka et al. MOLECULAR ENDOCRINOLOGY
- Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma
- (2010) M. Alberiche Ruano et al. Pituitary
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- Invasive Giant Prolactinoma with Loss of Therapeutic Response to Cabergoline: Expression of Angiogenic Markers
- (2009) María Susana Mallea-Gil et al. ENDOCRINE PATHOLOGY
- Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients
- (2009) Etienne Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Inhibitory effects of Group I metabotropic glutamate receptors antagonists on the expression of NMDA receptor NR1 subunit in morphine tolerant rats
- (2009) Jin-bian Liu et al. NEUROSCIENCE LETTERS
- Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review
- (2009) L. A. Behan et al. Pituitary
- Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma
- (2009) Alessandra Fusco et al. Pituitary
- Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
- (2008) Alessandra Fusco et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
- (2008) Masami Ono et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists
- (2008) Vanessa Q. Passos et al. NEUROENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now